Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
DEPT OF DEFENSE
This opportunity closed June 29, 2026. 5 similar opportunities are open right now.
Similar opportunities open now
- SWITCH,RADIO FREQUEOpenDEPT OF DEFENSECloses in 62 days
- 61--POWER SUPPLY - AND OTHER REPLACEMENT PARTSOpenDEPT OF DEFENSECloses today
- HEAT EXCHANGER,FLUIOpenDEPT OF DEFENSECloses in 6 days
- 59--CIRCUIT CARD ASSEMB- AND SIMILAR REPLACEMENT PARTSOpenDEPT OF DEFENSECloses in 7 days
- CCA,TRANSITIONOpenDEPT OF DEFENSECloses today
About this archived opportunity
The Department of Defense (DoD) is required by law (10 U.S.C. � 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DoD Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DoD Uniform Formulary (UF) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary (BCF), Extended Core Formulary (ECF), or non-formulary (NF). Prior to the scheduled P&T Committee meeting, a Request for Quotation (RFQ) for pharmaceutical agents within Drug Classes identified for placement on the UF has been issued to obtain quotes from industry. The Defense Health Agency may award Uniform Formulary Blanket Purchase Agreements (UF BPA) and the Uniform Formulary Additional Discount Program Agreements (UF ADP) based on the UF decision. This process is described in the attached RFQ. P&T COMMITTEE MEETING: The following May 2026 newly approved drugs will be reviewed: a. Lifyorli - Oncological Agents - Glucocorticoid Receptor Antagonist b. Quiofic - VITAMINS - WATER SOLUBLE c. Widaplik - ANTIHYPERTENSIVE AGENTS � N/A d. Saphnelo � IMMUNOSUPPRESSIVES � N/A The RFQ, including UF BPA and UF ADP appendices are attached here in. The instructions, important deadlines, and points of contact are in document, RFQ HT9402-26-Q-9302. Pre-quotation teleconference is on May 13, 2026. Details are stated in Part 2.4. Pre-Quotation Teleconference. Responses to the clinical questions in Part 3.4 shall be submitted via e-mail to the RFQ POC in Part 2.3.1., no later than the date stated in Part 2.3.2.
Historical details
- Status
- Closed
- Deadline
- June 29, 2026
- First captured
- May 8, 2026
- Publisher reference
- fdb09bd311224930bd4679692488acb0
This opportunity has closed
Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
by DEPT OF DEFENSE
Get notified when similar opportunities open
We'll save this search and email you when new pharmacy, uniform, formulary opportunities are posted. Free.
Related opportunities
- SWITCH,RADIO FREQUEDEPT OF DEFENSECloses in 62 days
- 61--POWER SUPPLY - AND OTHER REPLACEMENT PARTSDEPT OF DEFENSECloses today
- 61--POWER SUPPLY - AND OTHER REPLACEMENT PARTSDEPT OF DEFENSECloses in 11 days
- HEAT EXCHANGER,FLUIDEPT OF DEFENSECloses in 6 days
- 59--CIRCUIT CARD ASSEMB- AND SIMILAR REPLACEMENT PARTSDEPT OF DEFENSECloses in 7 days
- CCA,TRANSITIONDEPT OF DEFENSECloses today